Fecundis
PrivateLast Round
Seed
Oct 8, 2024
Est. Valuation
$6.72M
Total Funding Raised
$3.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fecundis operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Seed round in October 2024.
Fecundis is a biotechnology company that develops sperm-enhancing technologies to increase the success of infertility treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fecundis Comparables
Compare Fecundis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BAIBYS Fertility | 81% | |
| NeoGenix Biosciences | 78% | |
| The Cooper Companies | 77% |
For institutional investors. Book with your work email.
Fecundis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 8, 2024 | ||||
| Crowdfunding | Feb 9, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fecundis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zentynel Frontier Investments | Seed |
| DuneGlass Capital | Seed |
| GRIDX | Seed |
| Capital Cell | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 72% MoM.
- Oct 8, 2024
$2.4M round led by DuneGlass Capital
For institutional investors. Book with your work email.
Fecundis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fecundis's valuation, stock price, and market status.
Is Fecundis a public or private company?
Fecundis is a private company.
What is the current stock price of Fecundis?
Fecundis is a private company, so its shares have no public market price. Caplight tracks Fecundis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fecundis worth (valuation)?
Fecundis's valuation is estimated at $6.7M based on funding round data.
Can I buy Fecundis stock?
Fecundis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fecundis's last funding round?
Fecundis's most recent funding round was Seed on October 8, 2024.
Who are the main investors in Fecundis?
Key investors in Fecundis include DuneGlass Capital.
Will Fecundis IPO soon?
No public IPO plans have been announced for Fecundis.
How can I track Fecundis secondary market activity?
Caplight tracks bids, offers, and trades in Fecundis's shares on secondary markets.